<code id='B8538AC81C'></code><style id='B8538AC81C'></style>

<acronym id='B8538AC81C'></acronym>

<center id='B8538AC81C'><center id='B8538AC81C'><tfoot id='B8538AC81C'></tfoot></center><abbr id='B8538AC81C'><dir id='B8538AC81C'><tfoot id='B8538AC81C'></tfoot><noframes id='B8538AC81C'>

<optgroup id='B8538AC81C'><strike id='B8538AC81C'><sup id='B8538AC81C'></sup></strike><code id='B8538AC81C'></code></optgroup>

<b id='B8538AC81C'><label id='B8538AC81C'><select id='B8538AC81C'><dt id='B8538AC81C'><span id='B8538AC81C'></span></dt></select></label></b><u id='B8538AC81C'></u>

~~<i id='B8538AC81C'><strike id='B8538AC81C'><tt id='B8538AC81C'><pre id='B8538AC81C'></pre></tt></strike></i>~~

Home» leisure time» focus

focus

focus

author：leisure time 2025-10-02 00:02:04 Page View：474

light shines behind Pfizer CEO Albert Bourla as he attends a ceremony in Greece — Pfizer CEO Albert Bourla Giannis Papanikos/AP

Pfizer has a big problem. The drug giant hopes that new drugs to treat cancer are the solution.

Shares in the drugmaker fell 44% last year, and it now has a market capitalization of only $150 billion — a quarter that of Eli Lilly and half that of longtime rival Merck. In March of last year the company announced that it would spend $43 billion to buy Seagen, a maker of a hot category of oncology medicines called antibody-drug conjugates. Pfizer’s shares have slumped another 9% so far this year. On Thursday, executives are holding an investor briefing to try to convince shareholders that its bet will pay off.

advertisement

In an interview with STAT, Pfizer CEO Albert Bourla was insistent that the deal’s potential is being missed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Pope Francis asks Church to identify 21st
Next article： Jerome Adams on the need for new antivirals for Covid

comprehensive

In age of alternative facts, a scholarly course on calling out crap

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

AdobeU.S.legislationthatwouldsevertieswithChinesedrugmakerswouldjeopardizethedrugsupplyformillionsof

New air purifier tech could be key to improving indoor air quality

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

Search warrant issued in 1996 disappearance of Kristin Smart

1:31AnundatedphotoreleasedbytheFBIshowsKristinSmart,theCaliforniaPolytechnicStateUniversity,SanLuisO

read more